Source:http://linkedlifedata.com/resource/pubmed/id/17164371
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2006-12-13
|
pubmed:abstractText |
We conducted a nested case-control study within a cohort of elderly Americans to examine the role of the insulin-like growth factor (IGF) signaling pathway in prostate cancer etiology. The distribution of genotypes of IGF-I (CA)n, IGF binding protein-3 (IGFBP-3) A-202C, and of the 2-bp deletion and (AGG)n polymorphisms in IGF-I receptor (IGF-IR) was compared between men with prostate cancer (n = 213) and equal number of controls matched on year of blood draw, survival until the date of diagnosis, race, and age. Among controls, the number of CA repeats in IGF-I was not correlated to any appreciable degree with plasma IGF-I concentration, whereas the IGFBP-3 CC genotype was associated with a relatively low level of plasma IGFBP-3. There was no association between prostate cancer risk and the number of CA repeats in IGF-I, IGFBP-3 genotype, or the presence of the 2-bp deletion in IGF-IR. There was a small increased risk among men who did not carry two copies of the (AGG)7 allele of IGF-IR. These results add to the evidence that the number of IGF-I CA repeats is not associated with prostate cancer risk. Our observation that men who do not carry two copies of the IGF-IR (AGG)7 allele are at increased risk of prostate cancer merits further investigation.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1055-9965
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2461-6
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17164371-Aged,
pubmed-meshheading:17164371-Case-Control Studies,
pubmed-meshheading:17164371-Dinucleotide Repeats,
pubmed-meshheading:17164371-Genotype,
pubmed-meshheading:17164371-Humans,
pubmed-meshheading:17164371-Insulin-Like Growth Factor Binding Protein 3,
pubmed-meshheading:17164371-Insulin-Like Growth Factor I,
pubmed-meshheading:17164371-Male,
pubmed-meshheading:17164371-Polymorphism, Genetic,
pubmed-meshheading:17164371-Prostatic Neoplasms,
pubmed-meshheading:17164371-Receptor, IGF Type 1,
pubmed-meshheading:17164371-Risk Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
|
pubmed:affiliation |
Program in Epidemiology, Fred Hutchinson Cancer Research Center, WA, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|